Skip to main content
Premium Trial:

Request an Annual Quote

BGI, Collaborators to Establish Specialized College for Life Sciences, Biotech in China

NEW YORK (GenomeWeb) – BGI-Shenzhen, the South University of Science and Technology of China, and the University of Copenhagen announced recently a collaboration to establish a specialized college in Shenzhen, China.

BGI-Shenzhen said in a statement that the college will focus on "cultivating" world-class talent for the life sciences and biotech industry, "producing scientific research achievements with international influence and boosting the development of the [biotech] industry in China." It did not further elaborate on specific areas of interest on which the new college would concentrate.

"We have very strong experiences with the collaborations between Denmark and China," University of Copenhagen Vice President Thomas Bjørnholm said in a statement. "The best example is the collaboration in genomics that has been taking place for more than 20 years … We would like to contribute as much as we can to build a strong joint college as a strong strategic component and partnership."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.